Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026

Rhea-AI Summary

Rapid Micro Biosystems (Nasdaq: RPID) will release fourth quarter and full year 2025 financial results before market open on March 12, 2026.

Management will host a live webcast conference call at 8:30 a.m. ET on March 12, 2026, accessible via the company website; the webcast will be archived for replay after the event.

Key Figures

Earnings date: March 12, 2026 Earnings time: 8:30 a.m. ET Quarter reported: Fourth quarter 2025 +1 more

4 metrics

Earnings date March 12, 2026 Scheduled release of Q4 and full year 2025 results

Earnings time 8:30 a.m. ET Start time of webcast conference call

Quarter reported Fourth quarter 2025 Period to be reported with full year 2025

Full year reported Full year 2025 Annual financial results to be released

Market Reality Check

Price: $3.99 Vol: Volume 70,983 is below th...

low vol

$3.99 Last Close

Volume Volume 70,983 is below the 20-day average 222,452, suggesting subdued trading ahead of the earnings date announcement. low

Technical Shares at $3.99 are trading above the $3.42 200-day MA and about 19.23% below the $4.94 52-week high.

Peers on Argus

RPID gained 2.57% while peers were mixed: PROF and RCEL up, OWLT, SERA and LNSR ...

1 Up

RPID gained 2.57% while peers were mixed: PROF and RCEL up, OWLT, SERA and LNSR down, indicating stock-specific action rather than a broad sector move.

Historical Context

5 past events · Latest: Feb 12 (Negative)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 12	Inducement equity grants	Negative	-9.4%	Inducement RSUs and stock options granted to new employees.
Jan 13	Prelim 2025 revenues	Positive	-1.0%	Record preliminary Q4 and full‑year 2025 revenue update.
Jan 07	Conference presentation	Positive	-1.2%	Planned presentation at J.P. Morgan Healthcare Conference.
Nov 18	Growth capital funding	Positive	+5.3%	Announced <b>$45 million</b> growth capital commitment from Trinity Capital.
Nov 07	Q3 results, guidance	Positive	+12.7%	Q3 2025 results with raised full‑year revenue and placement guidance.

Pattern Detected

Recent news shows mixed alignment: positive fundamental updates sometimes led to gains, but preliminary revenue and conference news saw modest negative reactions, while financing and strong earnings updates coincided with notable upside.

Recent Company History

Over the past months, Rapid Micro Biosystems reported several milestones, including record Q3 2025 results and raised full‑year revenue guidance on Nov 7, 2025, and a $45 million growth capital commitment on Nov 18, 2025. Preliminary unaudited Q4 and full‑year 2025 revenues were highlighted on Jan 13, 2026, followed by inducement equity grants on Feb 12, 2026. Today’s earnings date announcement fits into this cadence of regular operational and financial disclosures ahead of final audited 2025 numbers.

Market Pulse Summary

This announcement sets the timing for Rapid Micro Biosystems’ fourth quarter and full year 2025 resu...

Analysis

This announcement sets the timing for Rapid Micro Biosystems’ fourth quarter and full year 2025 results on March 12, 2026, when management will host a webcast at 8:30 a.m. ET. In recent months, the company highlighted record preliminary 2025 revenue, raised guidance, and secured a $45 million growth capital commitment. Investors may focus on how final audited numbers compare with January’s preliminary figures and on any updated outlook commentary from management.

AI-generated analysis. Not financial advice.

LEXINGTON, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release fourth quarter and full year 2025 financial results prior to the market open on Thursday, March 12, 2026.

In conjunction with the release, the Company’s management team will host a webcast conference call at 8:30 a.m. ET on Thursday, March 12, 2026. The live audio webcast will be accessible on the Company’s website and can be accessed with this link. The webcast will be archived and available for replay after the event.

About Rapid Micro Biosystems

Rapid Micro Biosystems is an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The Company’s flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (“MQC”) testing workflows used in the largest and most complex pharmaceutical manufacturing operations across the globe. The Growth Direct system brings the quality control lab to the manufacturing floor, unlocking the power of MQC automation to deliver the faster results, greater accuracy, increased operational efficiency, better compliance with data integrity regulations, and quicker decision making that customers rely on to ensure safe and consistent supply of important healthcare products. The Company is headquartered Lexington, Massachusetts and has U.S. manufacturing in Lowell, Massachusetts, with global locations in Switzerland, Germany, and the Netherlands. For more information, please visit www.rapidmicrobio.com or follow the Company on X (formerly known as Twitter) at @rapidmicrobio or on LinkedIn. 

Investor Contact:
Michael Beaulieu, CFA
Vice President, Investor Relations and Corporate Communications
investors@rapidmicrobio.com 

Media Contact:
media@rapidmicrobio.com 

FAQ

When will Rapid Micro Biosystems (RPID) report Q4 and full year 2025 results?

Rapid Micro Biosystems will report results before market open on March 12, 2026. According to the company, the release covers both fourth quarter and full year 2025 financial results and precedes a management webcast at 8:30 a.m. ET the same day.

What time is the Rapid Micro Biosystems (RPID) earnings webcast on March 12, 2026?

The company will host a live webcast conference call at 8:30 a.m. ET on March 12, 2026. According to the company, the webcast is accessible on its website and will be archived for replay after the event for later listening.

How can investors access Rapid Micro Biosystems (RPID) March 12, 2026 webcast?

Investors can access the live audio webcast via the company's investor website using the provided webcast link. According to the company, the webcast will also be archived on the website for replay after the live event for on-demand access.

Will Rapid Micro Biosystems (RPID) provide a replay of the March 12, 2026 webcast?

Yes, the webcast will be archived and available for replay after the event. According to the company, the live audio webcast will be posted on its website and remain accessible for investors to review following the March 12, 2026 presentation.

What topics will Rapid Micro Biosystems (RPID) management cover on the March 12, 2026 call?

Management will discuss fourth quarter and full year 2025 financial results and related business updates. According to the company, the webcast will present the reported results and provide management commentary and investor Q&A during the March 12, 2026 call.